QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

CNMTICKER

Core & Main, Inc.

VERY BULLISH stock

Congress has disclosed 8 buys and 8 sells of CNM (Core & Main, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

8
Buy
8
Sell
+0
Net
3
Active politicians

Round-trip watch Still on the books

Members who disclosed buying CNM and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Michael McCaul 2025-09-22 $50.71 $44.25 -12.7% underwater

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Retail & Wholesale. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
16.46
▼ cheaper than Retail & Wholesale (median 23.0)
how it's calculated
P/E = price ÷ earnings per share
$44.25 ÷ $2.69 = 16.46
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
4.24
▼ cheaper than Retail & Wholesale (median 6.3)
how it's calculated
P/B = price ÷ book value per share
$44.25 ÷ $10.44 = 4.24
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
10.44
▼ cheaper than Retail & Wholesale (median 14.2)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($8.6B + $2.1B net debt) ÷ $1.0B = $10.7B ÷ $1.0B = 10.44
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

16 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
April McClain Delaney House SELL ◆ insider divergence · moderate Child 2026-08-25 7 days -4.6% $100K–$250K
0.1% of NW
65.8 ↗ filing
April McClain Delaney House SELL ◆ insider divergence · moderate Child 2026-06-12 19 days -6.0% $1K–$15K
<0.1% of NW
17.7 ↗ filing
Lisa McClain House SELL Spouse · Charles Schwab 401K > Schwab 893 2025-10-31 1 days 0.0% $1K–$15K
0.1% of NW
1.1 ↗ filing
Lisa McClain House SELL Spouse · Charles Schwab Brokerage Account 924 2025-10-30 2 days -0.2% $1K–$15K
0.1% of NW
7.8 ↗ filing
Lisa McClain House BUY Spouse · Charles Schwab 401K > Schwab 893 2025-10-30 2 days -0.2% $1K–$15K
0.1% of NW
7.8 ↗ filing
Michael McCaul House BUY OCR ◆ insider divergence Spouse 2025-09-22 13 days +3.6% $15K–$50K 47.5 ↗ filing
Lisa McClain House BUY ◆ insider divergence Spouse · Charles Schwab Brokerage Account 924 2025-09-11 20 days +6.4% $1K–$15K
0.1% of NW
24.5 ↗ filing
April McClain Delaney House SELL ◆ insider convergence Child 2025-08-04 35 days +4.3% $15K–$50K
<0.1% of NW
28.7 ↗ filing
Lisa McClain House SELL ◆ insider convergence Spouse · Charles Schwab Brokerage Account 924 2025-06-17 57 days +18.1% $1K–$15K
0.1% of NW
27.6 ↗ filing
Lisa McClain House BUY ◆ insider divergence Spouse · Charles Schwab Brokerage Account 924 2025-06-11 63 days +14.3% $1K–$15K
0.1% of NW
63.6 ↗ filing
April McClain Delaney House BUY ◆ insider divergence Child 2025-04-07 24 days +16.8% $1K–$15K
<0.1% of NW
25.8 ↗ filing
April McClain Delaney House BUY ◆ insider divergence Child 2025-02-08 21 days -6.6% $1K–$15K
<0.1% of NW
62.3 ↗ filing
Michael McCaul House SELL OCR ◆ insider convergence Spouse 2024-12-20 16 days +3.1% $1K–$15K 15.7 ↗ filing
Michael McCaul House BUY OCR ◆ insider divergence Spouse 2024-09-10 25 days +12.9% $15K–$50K 56.6 ↗ filing
Michael McCaul House BUY OCR ◆ insider divergence Child 2024-09-10 25 days +12.9% $15K–$50K 56.6 ↗ filing
Michael McCaul House SELL OCR ◆ insider convergence Spouse 2024-08-26 10 days -29.2% $1K–$15K 75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in CNM — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

4
Congress trades with insider convergence
9
…with insider divergence
155
Insider open-market trades

Of the congressional trades in CNM, 4 coincided with corporate insiders moving the same way within 60 days, and 9 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-07-06 Hope James D Director BUY $95K ↗ EDGAR
2026-04-17 Bradbury Robyn L C-suite SELL 10b5-1 $86K ↗ EDGAR
2026-04-17 Bradbury Robyn L C-suite SELL 10b5-1 $177K ↗ EDGAR
2026-04-07 Hope James D Director BUY $100K ↗ EDGAR
2025-08-18 Witkowski Mark R C-suite SELL 10b5-1 $6.4M ↗ EDGAR
2025-07-22 Bradbury Robyn L C-suite SELL 10b5-1 $323K ↗ EDGAR
2025-07-18 Kimbrough Orvin T Director SELL 10b5-1 $1.5M ↗ EDGAR
2025-07-18 Castellano James G Director SELL 10b5-1 $2.7M ↗ EDGAR
2025-07-17 Witkowski Mark R C-suite SELL 10b5-1 $4.4M ↗ EDGAR
2025-07-17 Witkowski Mark R C-suite SELL 10b5-1 $1.7M ↗ EDGAR
2025-07-07 LeClair Stephen O Director SELL $2.8M ↗ EDGAR
2025-07-03 LeClair Stephen O Director SELL $5.0M ↗ EDGAR
2025-07-01 Bradbury Robyn L C-suite SELL 10b5-1 $801K ↗ EDGAR
2025-07-01 Bradbury Robyn L C-suite SELL 10b5-1 $691K ↗ EDGAR
2025-07-01 Bradbury Robyn L C-suite SELL 10b5-1 $20K ↗ EDGAR
2025-06-09 Whittenburg Mark G Other SELL 10b5-1 $2.9M ↗ EDGAR
2025-06-06 Whittenburg Mark G Other SELL 10b5-1 $54K ↗ EDGAR
2025-06-03 Schneider Laura K C-suite SELL 10b5-1 $2.6M ↗ EDGAR
2025-05-28 Schaller John R Other SELL 10b5-1 $539K ↗ EDGAR
2025-04-29 Stephens John Weldon C-suite SELL 10b5-1 $1.7M ↗ EDGAR
2025-04-28 Stephens John Weldon C-suite SELL 10b5-1 $542K ↗ EDGAR
2025-04-02 Stephens John Weldon C-suite SELL 10b5-1 $2.1M ↗ EDGAR
2025-03-11 Schaller John R Other SELL 10b5-1 $868K ↗ EDGAR
2025-03-10 Schaller John R Other SELL 10b5-1 $1.0M ↗ EDGAR
2025-02-10 Cowles Bradford A C-suite SELL 10b5-1 $1.4M ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
Congress 2026-08-25 April McClain Delaney SELL $100K–$250K
◆ insider 2026-07-06 Hope James D Director BUY $95K
Congress 2026-06-12 April McClain Delaney SELL $1K–$15K
◆ insider 2026-04-17 Bradbury Robyn L C-suite 10b5-1 SELL $86K
◆ insider 2026-04-17 Bradbury Robyn L C-suite 10b5-1 SELL $177K
◆ insider 2026-04-07 Hope James D Director BUY $100K
Congress 2025-10-31 Lisa McClain SELL $1K–$15K
Congress 2025-10-30 Lisa McClain SELL $1K–$15K
Congress 2025-10-30 Lisa McClain BUY $1K–$15K
Congress 2025-09-22 Michael McCaul BUY $15K–$50K
Congress 2025-09-11 Lisa McClain BUY $1K–$15K
◆ insider 2025-08-18 Witkowski Mark R C-suite 10b5-1 SELL $6.4M
Congress 2025-08-04 April McClain Delaney SELL $15K–$50K
◆ insider 2025-07-22 Bradbury Robyn L C-suite 10b5-1 SELL $323K
◆ insider 2025-07-18 Kimbrough Orvin T Director 10b5-1 SELL $1.5M
◆ insider 2025-07-18 Castellano James G Director 10b5-1 SELL $2.7M
◆ insider 2025-07-17 Witkowski Mark R C-suite 10b5-1 SELL $4.4M
◆ insider 2025-07-17 Witkowski Mark R C-suite 10b5-1 SELL $1.7M
◆ insider 2025-07-07 LeClair Stephen O Director SELL $2.8M
◆ insider 2025-07-03 LeClair Stephen O Director SELL $5.0M
◆ insider 2025-07-01 Bradbury Robyn L C-suite 10b5-1 SELL $801K
◆ insider 2025-07-01 Bradbury Robyn L C-suite 10b5-1 SELL $691K
◆ insider 2025-07-01 Bradbury Robyn L C-suite 10b5-1 SELL $20K
Congress 2025-06-17 Lisa McClain SELL $1K–$15K

FAQ Common questions

How much has Congress traded CNM?

8 disclosed buys and 8 sells of CNM (Core & Main, Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade CNM?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.